B N Singh, D E Jewitt. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Action Potentials/drug effectsAdrenergic beta-Antagonists/adverse effectsAdrenergic beta-Antagonists/therapeutic useAlprenolol/therapeutic useArrhythmia, Sinus/drug therapyArrhythmias, Cardiac/chemically inducedArrhythmias, Cardiac/drug therapyArrhythmias, Cardiac/etiologyArrhythmias, Cardiac/physiopathologyArrhythmias, Cardiac/prevention & controlAtrial Fibrillation/drug therapyAtrial Flutter/drug therapyCardiac Surgical Procedures/adverse effectsCatecholamines/therapeutic useDepression, ChemicalDigitalis Glycosides/adverse effectsElectrocardiographyHumansMyocardial Infarction/drug therapyOxprenolol/therapeutic usePacemaker, ArtificialPindolol/therapeutic usePractolol/therapeutic usePropranolol/therapeutic usePurkinje Fibers/physiopathologyTachycardia/drug therapyTachycardia, Paroxysmal/drug therapyVentricular Fibrillation/drug therapyWolff-Parkinson-White Syndrome/drug therapy
Substances: See more » Adrenergic beta-AntagonistsCatecholaminesDigitalis GlycosidesOxprenololAlprenololPropranololPindololPractolol
Year: 1974 PMID: 4153572 DOI: 10.2165/00003495-197407060-00004
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546